Every 8-K that Ashland (ASH) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow ASH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ASH filings page.
Ashland Inc. filed an amendment to a prior report to provide additional details about board committee assignments for two recently appointed directors. The earlier report had disclosed the appointments of Allen A. Spizzo and Peter T. Thomas to the Board of Directors, effective July 27, 2026, but did not include their standing committee roles.
Effective August 7, 2026, the Board appointed Allen A. Spizzo to the Audit Committee and the Sustainability & Productivity Committee. On the same date, the Board appointed Peter T. Thomas to the Governance and Nominating Committee and the Compensation Committee. No other changes to the earlier disclosure were made.
Ashland Inc. entered into a Fifth Amendment to its Receivables Purchase Agreement on July 30, 2026 with PNC Bank, PNC Capital Markets and other parties. The accounts receivable securitization facility now provides commitments of up to $70 million.
The amendment extends the facility’s termination date to July 28, 2028, replacing a prior schedule under which commitments of up to $80 million applied from September 13, 2024 through December 31, 2024 and up to $70 million from January 1, 2025 through September 11, 2026. Related disclosures describe this as a direct financial obligation and an obligation under an off-balance sheet arrangement.
Ashland Inc. appointed Peter Thomas and Allen Spizzo as independent directors effective July 27, 2026, with initial terms running until the 2027 annual meeting of stockholders. With these appointments, the board temporarily expands to eleven members, with a planned reduction to ten members at the 2027 meeting.
The company also created a Capital Allocation Advisory Committee, initially with five voting directors, chaired by Scott A. Tozier with Peter Thomas as vice chair and CEO Guillermo Novo as a non-voting member, to support capital allocation strategy. Ashland entered into a Cooperation Agreement with Ancora Holdings Group and an investor group that includes voting commitments, standstill and mutual non-disparagement provisions for a defined standstill period tied to upcoming annual meeting cycles, plus a replacement-director right if the investor group maintains at least 1.5% beneficial ownership.
Ashland Inc. reported third‑quarter fiscal 2026 sales of $497 million, up seven percent from $463 million a year earlier, with volumes rising six percent across all business units. Net income was $16 million, versus a loss of $742 million, and income from continuing operations was $41 million, or $0.89 per diluted share.
Adjusted EBITDA was $109 million with a 21.9 percent margin, down four percent from $113 million as Life Sciences and Personal Care growth was more than offset by lower Specialty Additives and Intermediates earnings and the lingering impact of earlier lower production rates and inflationary cost pressures. Cash from operations reached $121 million, ongoing Free Cash Flow was $103 million, and net leverage stood at 2.4x.
The company reaffirmed full‑year fiscal 2026 sales guidance of $1,835–$1,870 million and Adjusted EBITDA guidance of $385–$400 million, while trimming its adjusted EPS growth outlook to low‑to‑mid single‑digit growth due to a higher tax rate from unfavorable discrete items.
Ashland Inc. entered into a Second Amended and Restated Credit Agreement providing a new $500 million, five-year unsecured revolving credit facility, including a $125 million letter of credit sublimit, available to Ashland and its Swiss subsidiary.
The facility replaces a prior 2022 agreement and will be used for ongoing working capital and general corporate purposes. Initial interest is Term SOFR or EURIBOR plus 1.375%, or an alternate base rate plus 0.375%, with pricing and unused commitment fees later tied to Ashland’s consolidated net leverage ratio and interest coverage metrics.
Ashland Inc. expanded its board of directors from eight to nine members and appointed Bertrand Loy as an independent director effective May 15, 2026. He will serve on the Audit Committee and the Governance and Nominating Committee.
Under Ashland’s non-employee director compensation program, Loy will receive a prorated annual grant of restricted stock units from his appointment date until the next annual award in January 2027 and is expected to stand for election at the 2027 Annual Meeting of Stockholders. A news release dated May 18, 2026, announcing his appointment is included as an exhibit.
Ashland Inc. reported second-quarter fiscal 2026 results and cut its full-year outlook. Sales were $482 million, up one percent from the prior-year quarter, with generally flat volumes and a two percent pricing decline partly offset by favorable currency.
Net income was $16 million and income from continuing operations was $15 million, or $0.32 per diluted share. Adjusted income from continuing operations excluding intangibles amortization was $42 million, or $0.91 per diluted share.
Adjusted EBITDA was $98 million, down nine percent from $108 million, reflecting operational issues at the Hopewell facility, the Calvert City startup delay, weather disruptions and softer pricing. Operating cash flow improved to $50 million and ongoing free cash flow reached $29 million.
For full-year fiscal 2026, Ashland now guides sales to $1,835–$1,870 million and Adjusted EBITDA to $385–$400 million, citing slower-than-expected productivity ramp-up at Hopewell and softer energy-related demand, partly offset by resilient Life Sciences and Personal Care demand and ongoing pricing actions.
Ashland Inc. furnished a current report to share that it has announced preliminary results for its first fiscal quarter. The company refers investors to a separate news release, attached as Exhibit 99.1, for the detailed financial and operating information.
The same news release is being made available in the Investor Center on Ashland’s website. Ashland states that this information is being furnished, not filed, which limits how it is treated under securities laws and how it can be incorporated into other regulatory documents.
Ashland Inc. approved a one-time equity award for Chair and CEO Guillermo Novo with an award value of $2,000,000. The award is entirely in time-based restricted stock units that cliff-vest on December 31, 2028, if he remains employed through that date.
The grant will occur on the first business day two days after Ashland files its Form 10-Q for the first quarter of fiscal 2026, with the number of RSUs based on the 25-day average closing price on the grant date. The award is made under Ashland’s 2021 Omnibus Incentive Compensation Plan.
The RSUs will not accelerate upon Mr. Novo’s retirement before the vesting date, and he has waived any right to such acceleration. Pro-rated vesting can still apply if his employment is terminated without cause. Both Mr. Novo and Ashland agreed to give at least 180 days’ notice of a resignation without good reason or a termination without cause, with different notice rules applying after a change in control.
Ashland Inc. reported results of its annual stockholder meeting held on January 20, 2026. A quorum was achieved with 45,762,099 common shares represented, equal to 90.94% of shares outstanding and eligible to vote.
All nominated directors were elected, each receiving over 36 million votes in favor. Stockholders also ratified Ernst & Young LLP as Ashland’s independent registered public accounting firm for fiscal 2026 with 41,483,293 votes for, 109,138 against and 24,628 abstentions. In addition, a non-binding advisory resolution approving compensation for the company’s named executive officers passed with 36,593,493 votes for, 1,247,959 against and 64,001 abstentions.
Ashland Inc. furnished a current report describing its preliminary fourth-quarter and full fiscal year 2025 results and its fiscal year 2026 outlook. These details are provided in a news release dated November 4, 2025, which is attached as Exhibit 99.1 and incorporated by reference into the results discussion.
The company also states that the news release will be made available in the Investor Center section of its website. Ashland clarifies that the information in this report and the exhibit is being furnished, not filed, under securities laws and will not be incorporated by reference into other securities law filings.
Ashland Inc. reported a board change. On September 16, 2025, director Sergio Pedreiro submitted his resignation from the Board of Directors, effective September 30, 2025. He will also step down from the Compensation Committee and his role as Chair of the Audit Committee as of that date.
With his departure, the size of Ashland’s Board will be reduced from nine to eight directors. The company stated that Mr. Pedreiro’s resignation is not due to any disagreement with Ashland or its practices, indicating this is a governance change rather than a dispute-driven departure.